Optic Neuritis Clinical Trials

Find Optic Neuritis Clinical Trials Near You

A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• Adult men and women (aged 18 to 50 years) with the first episode of ON in the study eye, associated with unilateral visual loss.

• Onset of visual loss symptoms in the previous 12 days before first administration of study treatment.

Locations
United States
Michigan
Kahana Oculoplastic and Orbital Surgery
RECRUITING
Livonia
South Carolina
Medical University of South Carolina, Storm Eye Institute
RECRUITING
Charleston
Texas
UT Southwestern Medical Center (Ophthalmology CRU)
RECRUITING
Dallas
Neuro-Eye Clinical Trials
RECRUITING
Houston
Contact Information
Primary
Chief Development Officer
info@oculis.com
617-928-5886
Time Frame
Start Date: 2026-05-28
Estimated Completion Date: 2028-12
Participants
Target number of participants: 210
Treatments
Experimental: Privosegtor
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: Oculis

This content was sourced from clinicaltrials.gov